Agonist-promoted desensitization of adenylate cyclase is intimately associated with phosphorylation of the (3-adrenergic receptor in mammalian, avian, and amphibian cells. However, the nature of the protein kinase(s) involved in receptor phosphorylation remains largely unknown. We report here the identification and partial purification of a protein kinase capable of phosphorylating the agonist-occupied form of the purified (3-adrenergic receptor. The enzyme is prepared from a supernatant fraction from high-speed centrifugation of lysed kin-cells, a mutant of S49 lymphoma cells that lacks a functional cAMP-dependent protein kinase. The P-agonist isoproterenol induces a 5-to 10-fold increase in receptor phosphorylation by this kinase, which is blocked by the antagonist alprenolol. Fractionation ofthe kin-supernatant on molecular-sieve HPLC and DEAE-Sephacel results in a 50-to 100-fold purified (3-adrenergic receptor kinase preparation that is largely devoid of other protein kinase activities. The kinase activity is insensitive to cAMP, cGMP, cAMP-dependent kinase inhibitor, Ca2+-calmodulin, Ca2+-phospholipid, and phorbol esters and does not phosphorylate general kinase substrates such as casein and histones. Phosphate appears to be incorporated solely into serine residues. The existence of this novel cAMP-independent kinase, which preferentially phosphorylates the agonist-occupied form of the 3-adrenergic receptor, suggests a mechanism that may explain the homologous or agonist-specific form of adenylate cyclase desensitization. It also suggests a general mechanism for regulation of receptor function in which only the agonist-occupied or "active" form of the receptor is a substrate for enzymes inducing covalent modification.
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Desensitization is a general phenomenon in biology in which prolonged exposure of a cell to a hormone or drug results in a reduced responsiveness to further challenge by that agent. Two major types of desensitization have been described (1, 2) . Homologous, or agonist-specific, desensitization results in an attenuated response only to the desensitizing agent. Heterologous desensitization, on the other hand, results in a more general decrease in responsiveness to a wider variety of hormonal agents as well as to nonhormonal stimulators.
One of the most thoroughly studied model systems for desensitization is the ,B-adrenergic receptor-coupled adenylate cyclase (3) . This receptor mediates catecholamine stimulation of adenylate cyclase via interaction with the stimulatory guanine nucleotide regulatory protein (4) . Both heterologous and homologous forms of desensitization have been characterized. While clear distinctions between the two forms exist, one central feature that is common to both is that the /3-adrenergic receptor is stoichiometrically phosphorylated during desensitization (5) (6) (7) . Studies of heterologous desensitization carried out largely with avian erythrocytes have demonstrated that the cAMP-dependent protein kinase is involved in this process (8) (9) (10) . Moreover, it has been shown in vitro that the isolated j-adrenergic receptor can be stoichiometrically phosphorylated by the pure catalytic subunit of the cAMP-dependent protein kinase. Furthermore, such phosphorylated receptors are functionally impaired in their coupling to the effector components of the adenylate cyclase system as assessed in reconstituted systems (11) .
In contrast, homologous desensitization of the P-adrenergic receptor is clearly not cAMP-mediated. P-Adrenergic receptor phosphorylation has been demonstrated to accompany homologous desensitization not only in frog erythrocytes (6) and wild-type S49 cells (7) but also in mutants [cyc-(coupling-protein deficient) and kin-(cAMP-dependent protein kinase deficient)] of the S49 cells that cannot mount an agonist-promoted cAMP-dependent protein kinase response (7) . This demonstrates that cAMP production and the cAMPdependent protein kinase are not required for receptor phosphorylation and homologous desensitization in these cells. Thus, the relevant kinase(s) must either be stimulated by a second messenger other than cAMP or preferentially phosphorylate the agonist-occupied form of the receptor. In the present work we have identified a novel protein kinase in lysates of kin-cells that phosphorylates the -3-adrenergic receptor in an almost totally agonist-dependent fashion.
MATERIALS AND METHODS Materials. Most chemicals were from sources previously described (11, 12) . Histone (types II-AS, V-S, and VII-S), casein, protein kinase inhibitor (type II), phorbol 12-myristate 13-acetate (PMA), and calmodulin were from Sigma. Dulbecco's modified Eagle's medium, phosphatebuffered saline, and horse serum were from GIBCO.
Purification and Reconstitution of Receptor. The -adrenergic receptor from hamster lung was purified to >95% homogeneity by sequential affinity and HPLC as described (12) . The purified receptor (typically 30-60 pmol) was reconstituted by incubating with bovine serum albumin (1 mg), sonicated soybean phosphatidylcholine (2.5 mg), and octyl glucoside (5 mg) before chromatography on 1-ml Extracti-gel columns as described (11) . The eluates (2 ml) were incubated with 0.6 ml 50% polyethylene glycol for 10 min at 22°C, diluted with ice-cold 100 mM NaCl/10 mM Tris-HCl, and centrifuged at 300,000 x g for 1.5 hr at 4°C. The protein-lipid pellets were resuspended in 50-100 ,ud of 100 mM NaCl/10 mM Tris4HCl, pH 7.2. The efficiency of receptor insertion Abbreviations: PMA, phorbol 12-myristate 13-acetate; N, stimulatory guanine nucleotide regulatory protein; kin-, cAMP-dependent protein kinase deficient.
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Partial Purification of I3-Adrenergic Receptor Kinase. The soluble kin-cell lysate was initially fractionated by molecular-sieve HPLC (Fig. 2) . This resulted in virtually complete separation of the f-adrenergic receptor kinase activity from the major peaks of histone 2B kinase and protein kinase C. This step also resulted in an -3-fold increase in the specific activity of the 3-adrenergic receptor kinase. The additional small peak of receptor phosphorylation coinciding with the protein kinase C activity most likely represents phosphorylation of the receptor by protein kinase C as it is enhanced by the inclusion of Ca2l and phospholipid in the assay. The peak of P-adrenergic receptor kinase activity from the HPLC was pooled and next chromatographed on a DEAESephacel column (Fig. 3) . The receptor kinase passed through the column unretarded, resulting in an apparent complete separation from the residual histone 2B kinase activity and an additional -25-fold increase in specific activity. This kinase preparation was used in all further studies. The fact that the receptor kinase did not interact with the DEAE column distinguishes it from a number of other kinases, including the cAMP-dependent and Ca2+/phospholipid-dependent kinases. An additional small peak of receptor kinase activity was eluted after the major peak. This activity was seen in several preparations and appeared to increase when cells were lysed in the absence of EDTA.
Specificity of the 3-Adrenergic Receptor Kinase. Receptor phosphorylation by DEAE-Sephacel-purified kinase was not affected by cAMP, cGMP, cAMP-dependent kinase inhibitor, Ca2W/calmodulin or Ca2+/phosphatidylserine/PMA (Table 1) .
These results clearly demonstrate that the receptor kinase is not a cAMP-dependent, cGMP-dependent, Ca2+/calmoduiin-dependent, or Ca2+/phospholipid-dependent protein kinase. The specificity of the receptor kinase was further assessed by using mixed-type histones and casein as substrates. These proteins did not appear to be phosphorylated under conditions where the receptor was (data not shown). The receptor kinase appeared to be specific for serine residues, as phosphoamino acid determination revealed only phosphoserine.
Time Course of Receptor Phosphorylation. The time course of receptor phosphorylation in the presence or absence of isoproterenol is shown in Fig. 4 . The striking increase in phosphorylation promoted by agonist (11-fold at 1 hr) clearly shows that agonist occupancy is virtually required for receptor phosphorylation. The increased fold stimulation of receptor phosphorylation by agonist seen with DEAESephacel-purified vs. crude kinase preparations (11-fold vs. 5-fold) most likely reflects some agonist-independent phosphorylation of the receptor by protein kinase C or other kinases in the cruder preparations. These data are in contrast to previous work with the cAMP-dependent protein kinase (11) . In those studies, -3-adrenergic receptor phosphorylation was also enhanced by agonist occupancy; however, that effect was observed only as a 2-to 3-fold increase in the rate ofphosphorylation, with no apparent change in the maximum stoichiometry obtained. Again this underscores the differences between the /-adrenergic receptor kinase and the cAMP-dependent protein kinase.
The relatively low stoichiometry obtained with the /-adrenergic receptor kinase (=0.2 mol/mol) is likely due to several contributing factors. These include the relatively low amounts of kinase used in these studies (-1-10%o ofthat used in the cAMP-dependent kinase studies; ref. 11) along with the impurity ofthe kinase preparation. In addition, it is clear from the time course (Fig. 4) Ca2l (1.0 mM)/calmodulin (6 j.g)
Ca2+ (1.0 mM)/PtdSer (10 ;Lg)/PMA (0.02 mM)
The phosphorylation of ,3-adrenergic receptor (5 pmol) in the presence of 2 AM (-)-isoproterenol and DEAE-purified receptor kinase (1.5 pg) was studied in the presence or absence of various protein kinase modulators. Assay conditions were as described.
Phosphorylation in the control was -0.15 mol of 32p per mol of receptor. The data shown are the mean ± range of two experiments.
PtdSer, phosphatidylserine. (Inset) Resulting autoradiogram after a 9-hr exposure ofthe dried gel. Phosphorylation stoichiometries were determined by counting the excised receptor bands as described (11) . In calculating the stoichiometries, it was assumed that only half of the receptors in phosphatidylcholine vesicles were accessible to the kinase. This assumption was based on two lines of evidence. First, previous studies with the cAMP-dependent protein kinase showed that only z50%o of the maximum phosphorylation could be achieved when the kinase was present only on the outside ofthe vesicles (11) . In addition only 50%o of the reconstituted receptors were accessible to deglycosylation by the enzyme endoglycosidase F (data not shown). One of the most potentially interesting roles of the 13-adrenergic receptor kinase might be its involvement in homologous desensitization. The mechanisms by which such receptor phosphorylation might lead to homologous desensitization are, however, currently unknown. One possibility is that the phosphorylated receptor has diminished ability to interact with the guanine nucleotide regulatory protein. Such a mechanism would be similar to that found for the cAMPdependent protein kinase in heterologous desensitization (8) (9) (10) (11) . Studies on human astrocytoma cells (17, 18) Another aspect of receptor phosphorylation is the role, if any, of a receptor kinase in heterologous desensitization. At present only the cAMP-dependent protein kinase is known to be involved in heterologous desensitization (8) (9) (10) (11) 23) . However, only "50% of the total receptor phosphorylation and desensitization is accounted for by this kinase (8, 10, 11, 23) . While the cAMP-dependent kinase provides a heterologous or nonselective effect on the system because of its broad substrate specificity, the receptor kinase might impart at least some agonist specificity.
A striking analogy can be drawn between the lightactivated phosphodiesterase system of rod outer segments and the adenylate cyclase system. In the phosphodiesterase system, enzyme activity is mediated by the light-dependent interaction of rhodopsin, a receptor for light, with transducin, a guanine nucleotide regulatory protein (24) . A potential role for phosphorylation in the regulation of this system was noted by a number of groups in the early 1970s when they discovered a light-dependent phosphorylation of rhodopsin (25) (26) (27) . The kinase involved appears to be highly specific for bleached rhodopsin as a substrate (28, 29) and has been aptly named rhodopsin kinase. Shichi et al. have been able to demonstrate that phosphorylated rhodopsin has a reduced ability to interact with transducin, thus providing a mechanism for the light-induced "desensitization" observed in this system (30) . Moreover, Somers and Klein have shown that the rat pineal gland contains high levels of a rhodopsin kinase-like activity while lacking the photoreceptor rhodopsin (31) . They speculate that pineal rhodopsin kinase may be involved in regulating adrenergic responsiveness in these cells. The potential relationship between rhodopsin kinase, pineal rhodopsin kinase, and the ,3adrenergic receptor kinase will be of interest to determine (11) .
In summary, we have identified and partially purified a novel protein kinase that preferentially phosphorylates the agonist-occupied form of the 3-adrenergic receptor. This kinase may play an important role in regulating the function of the /3-adrenergic receptor as well as other adenylate cyclase-coupled receptors, as in homologous desensitization. Moreover, the existence of such a kinase suggests a general mechanism for regulating receptor function-i.e., that only relevant regulatory enzymes. Such a mechanism would explain the intimate linkage of receptor activation and desensitization. Future studies will focus on the determination of the ability of this kinase to phosphorylate other receptors and on an examination of the functionality of the phosphorylated receptors. However, such investigations will require further purification of the enzyme.
